Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
Wen-Chien Wang, Ekramy E. Sayedahmed, Suresh K. Mittal
Viruses (2022) Vol. 14, Iss. 12, pp. 2727-2727
Open Access | Times Cited: 19

Showing 19 citing articles:

Development of NP-Based Universal Vaccine for Influenza A Viruses
Ekramy E. Sayedahmed, Nelly O. Elshafie, Andrea Pires dos Santos, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 157-157
Open Access | Times Cited: 10
In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology
Julie Schock Vaiani, Mans Broekgaarden, Jean‐Luc Coll, et al.
Nanoscale (2025)
Closed Access | Times Cited: 1
Innate Immune Response to Viral Vectors in Gene Therapy
Yixuan Wang, Wenwei Shao
Viruses (2023) Vol. 15, Iss. 9, pp. 1801-1801
Open Access | Times Cited: 17
Clinical Application of Adenovirus (AdV): A Comprehensive Review
Md. Salauddin, Sukumar Saha, Md. Golzar Hossain, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 8
Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses
Anyeseu Park, Jeong Yoon Lee
The Journal of Microbiology (2024) Vol. 62, Iss. 7, pp. 491-509
Closed Access | Times Cited: 8
Urgent considerations for booster vaccination strategies against Ebola virus disease
Wim Adriaensen, Selien Oostvogels, Yves Lévy, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. e647-e653
Closed Access | Times Cited: 7
Methods to mitigate immune response
Chioma C. Ezeuko, Bernard B. Efa, Qiana L. Matthews
Elsevier eBooks (2025), pp. 275-308
Closed Access
Adenoviral vector construction I: Mammalian systems
Peter Abbink, Wilfried A.M. Bakker, Menzo Havenga, et al.
Elsevier eBooks (2025), pp. 99-130
Closed Access
Systems of adenoviral gene transfer vectors moving into their fourth generation
Qi Yan, Janae Wheeler Cull, E. Bart Tarbet, et al.
Elsevier eBooks (2025), pp. 403-432
Closed Access
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2
Muralimanohara S. T. Murala, Vivek Gairola, Ekramy E. Sayedahmed, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 406-406
Open Access
Development of viral infectious clones and their applications based on yeast and bacterial artificial chromosome platforms
Yiyi Wu, Shangqing Gao, G. Liu, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings
Yanqun Wang, Peilan Wei, Jun Zhang, et al.
hLife (2025)
Open Access
Past, Present, and Future of Viral Vector Vaccine Platforms: A Comprehensive Review
Justin Tang, Md. Al Amin, Jian L. Campian
Vaccines (2025) Vol. 13, Iss. 5, pp. 524-524
Open Access
Advances in gene therapy for high-grade glioma: a review of the clinical evidence
Matthew Goldman, Alexandra M. Baskin, Martyn A. Sharpe, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 9, pp. 879-895
Closed Access | Times Cited: 2
Effects of Common Anti-Inflammatories on Adenovirus Entry and Their Physicochemical Properties: An In-Depth Study Using Cellular and Animal Models
Héctor R. Galván‐Salazar, Marina Delgado‐Machuca, Gustavo A. Hernández‐Fuentes, et al.
Microbiology Research (2024) Vol. 15, Iss. 3, pp. 1590-1604
Open Access | Times Cited: 2
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
Xavier Sáez‐Llorens, Ximena Norero, Marisa Márcia Mussi‐Pinhata, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 95-107
Open Access | Times Cited: 4
Optoelectronic control of cardiac rhythm: Toward shock‐free ambulatory cardioversion of atrial fibrillation
Vincent Portero, Shanliang Deng, Gerard J.J. Boink, et al.
Journal of Internal Medicine (2023) Vol. 295, Iss. 2, pp. 126-145
Open Access | Times Cited: 4
Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer
Alejandro J. Nicola Candia, Matías Garcia Fallit, Jorge A. Peña Agudelo, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1813-1813
Open Access | Times Cited: 3
Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector
Ekramy E. Sayedahmed, Nelly O. Elshafie, Guangjun Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Smart Cell Therapy: an industry perspective on macrophages as living drugs
David T. Rodgers, Tatiana I. Novobrantseva, Rita N. Bárcia
Cytotherapy (2024)
Closed Access
Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
Thomas Dobner, Luca D. Bertzbach
Viruses (2023) Vol. 15, Iss. 2, pp. 514-514
Open Access
Page 1

Scroll to top